Skip to content

13F-HR filed by TANG CAPITAL MANAGEMENT LLC

TANG CAPITAL MANAGEMENT LLC filed this 13F-HR for the quarter ended 2014-12-31, filed 2015-01-27, with 9 holding rows worth $182,383,000.

Accession
0001214659-15-000607
Filed
2015-01-27
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2014

A holdings report, 11 entries on the cover page, a total value of $182,383,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $182,383,000 with VALUE read as thousands by filing date, 13F file number 028-14822. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
HERON THERAPEUTICS INC427746102COM4,919,625$49,491,000thousands by filing date
LA JOLLA PHARMACEUTICAL CO503459604COM PAR $.0001 22,144,387$39,564,000thousands by filing date
SALIX PHARMACEUTICALS INC795435106COM300,000$34,482,000thousands by filing date
OPKO HEALTH INC68375NAB9DEBT 3.000% 2/014,000,000$20,573,000thousands by filing dateprincipal
BIOMARIN PHARMACEUTICAL INC09061G101COM182,300$16,480,000thousands by filing date
MERRIMACK PHARMACEUTICALS IN590328AA8NOTE 4.500% 7/15,500,000$10,225,000thousands by filing dateprincipal
HORIZON PHARMA PLCG4617B105SHS490,000$6,316,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM238,432$4,416,000thousands by filing date
ONCOGENEX PHARMACEUTICALS IN68230A106COM365,000$836,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001214659-15-000607this filing2015-01-27acceptance time not in the bulk data set